Glutamine derivatives as novel anticancer agents acting via gastrin binding sites
- 1 June 1990
- journal article
- research article
- Published by Elsevier in Medical Hypotheses
- Vol. 32 (2) , 85-88
- https://doi.org/10.1016/0306-9877(90)90028-d
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Gastrin and Somatostatin Levels in Patients with Gastric CancerHormone and Metabolic Research, 1989
- Influence of pentagastrin and proglumide on human colonic carcinoma transplanted to nude miceActa Endocrinologica, 1988
- Role of gastrin and cholecystokinin in tumours of the gastrointestinal tractEuropean Journal of Cancer and Clinical Oncology, 1988
- High affinity binding of cholecystokinin to small cell lung cancer cellsPeptides, 1987
- Effects of Gastrin, Glutamine, and Somatostatin on the In Vitro Growth of Normal and Malignant Human Gastric Mucosal CellsArchives of Surgery, 1986
- Regulatory effects of gastrin and secretin on carcinomas of the stomach and colon.The Tohoku Journal of Experimental Medicine, 1986
- Gastrin receptors in normal and malignant gastrointestinal mucosa: age-associated changesAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 1985
- Proglumide, A Gastrin Receptor Antagonist, Inhibits Growth of Colon Cancer and Enhances Survival in MiceAnnals of Surgery, 1985
- Neural regulation of pancreatic hormone secretion by the C-terminal tetrapeptide of CCKNature, 1980
- A review of some recent developments in the chemistry of the gastrinsBioorganic Chemistry, 1979